locommotion: analysis of soc for r/r myeloma
Published 3 years ago • 58 plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
1:47
cilta-cel in earlier lines of therapy for r/r multiple myeloma
-
1:41
key findings of the locommotion study
-
2:32
updates on the use of melflufen in r/r multiple myeloma
-
1:02
the role of selinexor in the treatment of multiple myeloma
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:06
updates from the locommotion study
-
2:21
the role of melflufen in the myeloma treatment landscape
-
6:23
results of maintenance therapy in high-risk myeloma patients | ajay nooka, md, mph, facp | asco 2023
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
0:52
is there a role for combination therapy in cml?
-
2:06
the importance of proteomic analysis in myeloma and future outlooks
-
1:16
the evolving use of selinexor in multiple myeloma
-
0:50
the expanding therapeutic landscape of r/r multiple myeloma
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
2:46
managing patients with high-risk myeloma
-
1:50
molecular characteristics of extramedullary myeloma
-
2:44
myeloma qol through induction and maintenance
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
3:41
emerging therapies for r/r myeloma
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
0:57
the potential of the tsafinder tool in hematological oncology